Creative – CounterX Therapeutics

Home
About
Platform
Pipeline
- CTRX 101
- Publications
Team
News
Contact

Search Posts

Search

About Us

Lorem ipsum dolor sit amet, consectetur adipisc glelit, sed do eiusmod tempor incididunt .ut labo et dolore magna aliqua.

Blog Categories

Press Release (1)
Publications (9)

Recent Posts

October 29, 2025

CounterX Therapeutics Announces Publication Demonstrating CTRX-101, an Anti-Fentanyl Monoclonal Antibody Therapy, Reverses Fentanyl-Induced Overdose in Preclinical Model

Post placeholder image

October 10, 2025

An anti-fentanyl monoclonal antibody reverses fentanyl-induced apnea in pigs

Post placeholder image

January 21, 2025

Psychopharmacology: A humanized monoclonal antibody attenuates fentanyl self-administration and reverses and prevents fentanyl-induced ventilatory depression in rhesus monkeys

Post placeholder image

October 7, 2024

ACS Omega: Structure-Based Engineering of Monoclonal Antibodies for Improved Binding to Counteract the Effects of Fentanyl and Carfentanil

Post placeholder image

The Journal of Immunology: Monoclonal Antibodies Engineered with Fc Region Mutations to Extend Protection against Fentanyl Toxicity

Post placeholder image

Expert Opinion Investigational Drugs: The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis

Recent Comments

No comments to show.

Tags

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Follow Us
Contact Us

©2025 CounterX Therapeutics. All Rights Reserved.